Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques

The selective estrogen receptor modulator (SERM), tamoxifen, effectively slows the progression of estrogen-positive breast cancer and aids in the prevention of cancer in at-risk women. Tamoxifen is well characterized with regards to its effects on breast cancer, but its effects on other estrogen-related systems, particularly neural circuits regulating brain function and mood, are poorly understood. Using ovariectomized rhesus monkeys, we examined the effects of tamoxifen, with and without estrogen replacement therapy (ERT), on social behavior and central serotonin (5HT) systems thought to influence these behaviors. Relative to placebo treatments, estrogen treatment increased serotonergic tone, based on response in prolactin and cortisol to fenfluramine, a 5HT releasing agent. Tamoxifen neither blocked nor enhanced this effect, indicating it to be neither an antagonist nor an agonist on serotonergic activity. In contrast, CSF measures of the 5HT metabolite, 5HIAA, were not significantly affected by treatment. Tamoxifen-treated animals showed increases in measures of anxiety, compared with ERT-treated animals, suggesting that this SERM may be anxiogenic. Co-treatment with estrogen attenuated the anxiogenic properties of tamoxifen. These data show that tamoxifen administration increased anxiety levels, but the affect was not associated with differences in central levels of the serotonin tone.

[1]  M. Wilson,et al.  Reproductive Performance in Capture‐Acclimated Female Rhesus Monkeys (Macaca mulatta) , 1982, Journal of medical primatology.

[2]  D. Pfaff,et al.  Estrogens, brain and behavior: studies in fundamental neurobiology and observations related to women's health , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  C. Nemeroff,et al.  Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. , 2002, The Journal of pharmacology and experimental therapeutics.

[4]  Bruce McEwen,et al.  Gender differences in age-related changes in HPA axis reactivity , 2001, Psychoneuroendocrinology.

[5]  D. Middlemiss,et al.  Serotonergic targets in depression. , 2002, Current opinion in pharmacology.

[6]  M. Wilson,et al.  Serum 17β-estradiol and progesterone associated with mating behavior during early pregnancy in female rhesus monkeys , 1982, Hormones and Behavior.

[7]  J. Streicher,et al.  Diverse Actions of Ovarian Steroids in the Serotonin Neural System , 2002, Frontiers in Neuroendocrinology.

[8]  G. Fink,et al.  Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. , 1999, Brain research. Molecular brain research.

[9]  H. Critchley,et al.  Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women , 2001, Psychoneuroendocrinology.

[10]  B. Breuer,et al.  The Relationship of Tamoxifen with Dementia, Depression, and Dependence in Activities of Daily Living in Elderly Nursing Home Residents , 2000, Women & health.

[11]  T. Dinan,et al.  Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. , 1996, Life sciences.

[12]  F. Petraglia,et al.  Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. , 1993, Fertility and sterility.

[13]  R. Blakely,et al.  Biogenic amine transporters: regulation in flux , 2000, Current Opinion in Neurobiology.

[14]  S. Manuck,et al.  Cholesterol, Serotonin, and Behavior in Young Monkeys , 1996, Annals of the New York Academy of Sciences.

[15]  T. Insel,et al.  Serotonin and neuropeptides in affiliative behaviors , 1998, Biological Psychiatry.

[16]  J. Younger,et al.  Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. , 1999, Psychosomatics.

[17]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[18]  M. Wilson,et al.  Effects of capture and venipuncture on serum levels of prolactin, growth hormone and cortisol in outdoor compound-housed female rhesus monkeys (Macaca mulatta). , 1983, Acta endocrinologica.

[19]  R. Lindsay,et al.  Selective estrogen receptor modulators: clinical spectrum. , 1999, Endocrine reviews.

[20]  J. Mann,et al.  Blunted Serotonergic Responsivity in Depressed Inpatients , 1995, Neuropsychopharmacology.

[21]  S. Birge.  The role of estrogen in the treatment and prevention of dementia: introduction. , 1997, The American journal of medicine.

[22]  M D'Antoni,et al.  Scratching as a behavioral index of anxiety in macaque mothers. , 1991, Behavioral and neural biology.

[23]  A. Gjerris.  Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression? , 1988, Acta psychiatrica Scandinavica. Supplementum.

[24]  R. Rose,et al.  Aggression and social controls in rhesus monkey (Macaca mulatta) groups revealed in group formation studies. , 1974, Folia primatologica; international journal of primatology.

[25]  S. Goldstein.  The Effect of SERMs on the Endometrium , 2001, Annals of the New York Academy of Sciences.

[26]  V. Jordan,et al.  Novel agents to modulate oestrogen action. , 2000, British medical bulletin.

[27]  R. Ramasubbu,et al.  A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls. , 1999, Journal of affective disorders.

[28]  R. Day.  Quality of Life and Tamoxifen in a Breast Cancer Prevention Trial , 2001 .

[29]  D. Rubinow,et al.  Estrogen–serotonin interactions: implications for affective regulation , 1998, Biological Psychiatry.

[30]  J. Nurnberger,et al.  Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research , 1988, Psychiatry Research.

[31]  C. Soares,et al.  Effect of Reproductive Hormones and Selective Estrogen Receptor Modulators on Mood during Menopause , 2003, Drugs & aging.

[32]  M. Liebowitz,et al.  The social anxiety spectrum. , 2002, The Psychiatric clinics of North America.

[33]  G. Schino,et al.  Primate displacement activities as an ethopharmacological model of anxiety. , 1996, Anxiety.

[34]  M. Fava.  New approaches to the treatment of refractory depression. , 2000, The Journal of clinical psychiatry.

[35]  L. Kahn,et al.  Role of Estrogen in the Aetiology and Treatment of Mood Disorders , 2001, CNS drugs.

[36]  D. Hadzi-Pavlovic,et al.  Fifteen years on: evolving ideas in researching sex differences in depression , 1997, Psychological Medicine.

[37]  A. Lees,et al.  Mood Disorder in Women with Early Breast Cancer Taking Tamoxifen, an Estradiol Receptor Antagonist , 1995, Annals of the New York Academy of Sciences.

[38]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[39]  H. Imura,et al.  Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells. , 1983, Life sciences.

[40]  Alfonso Troisi,et al.  Displacement Activities as a Behavioral Measure of Stress in Nonhuman Primates and Human Subjects , 2002, Stress.

[41]  S. Stahl.  Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment. , 1998, The Journal of clinical psychiatry.

[42]  V. Vogel,et al.  The Relationship Between Tamoxifen, Estrogen, and Depressive Symptoms , 1999, The breast journal.

[43]  L. Uphouse.  Multiple Serotonin Receptors: Too Many, Not Enough, or Just the Right Number? , 1997, Neuroscience & Biobehavioral Reviews.

[44]  M. Axthelm,et al.  Self-Injurious Behavior Is Decreased by Cyproterone Acetate in Adult Male Rhesus (Macaca mulatta) , 1999, Hormones and Behavior.

[45]  P. Cowen,et al.  Brain 5-HT neurotransmission during paroxetine treatment , 1998, British Journal of Psychiatry.

[46]  D. Dluzen,et al.  Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system , 2000, Journal of neurocytology.

[47]  S. Kubota,et al.  Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum , 2001, Neuroscience Letters.

[48]  M. Antoni,et al.  Elevated basal cortisol levels and attenuated acth and cortisol responses to a behavioral challenge in women with metastatic breast cancer , 1996, Psychoneuroendocrinology.

[49]  S. Feldman,et al.  The Excitatory Effects of the Amygdala on Hypothalamo-Pituitary-Adrenocortical Responses Are Mediated by Hypothalamic Norepinephrine, Serotonin, and CRF-41 , 1998, Brain Research Bulletin.

[50]  C. Shively,et al.  Triphasic oral contraceptive treatment alters the behavior and neurobiology of female cynomolgus monkeys , 2004, Psychoneuroendocrinology.

[51]  R. Bonsall,et al.  Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis , 2003, Neuropsychopharmacology.

[52]  S. Altmann,et al.  A FIELD STUDY OF THE SOCIOBIOLOGY OF RHESUS MONKEYS, MACACA MULATTA * , 1962, Annals of the New York Academy of Sciences.

[53]  F. Graeff,et al.  Role of 5-HT in stress, anxiety, and depression , 1996, Pharmacology Biochemistry and Behavior.

[54]  J. Flory,et al.  Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. , 2004, The Journal of clinical endocrinology and metabolism.

[55]  N. Kalin.  Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems. , 2003, The Journal of clinical psychiatry.

[56]  B. Sherwin.  Oestrogen and cognitive function throughout the female lifespan. , 2000, Novartis Foundation symposium.

[57]  A. Janowsky,et al.  Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques* , 2003, Molecular Psychiatry.

[58]  S. Reichlin.  Neuroendocrinology of the Pituitary Gland , 1989, Toxicologic pathology.

[59]  H. Bryant,et al.  Selective Estrogen Receptor Modulators: An Alternative to Hormone Replacement Therapy , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[60]  S. Garattini,et al.  d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. , 1986, European journal of pharmacology.

[61]  K. Wallen.  Desire and ability: Hormones and the regulation of female sexual behavior , 1990, Neuroscience & Biobehavioral Reviews.

[62]  K. Wallen,et al.  Periovulatory changes in female sexual behavior and patterns of ovarian steroid secretion in group-living rhesus monkeys , 1984, Hormones and Behavior.

[63]  A. Cleare,et al.  Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans , 1999, Psychopharmacology.

[64]  L. Schneider,et al.  Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. , 1997, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[65]  P. Mitchell,et al.  Hormonal responses to fenfluramine in depressed and control subjects. , 1990, Journal of affective disorders.

[66]  V. Jordan,et al.  Selective oestrogen receptor modulation: molecular pharmacology for the millennium. , 1999, European journal of cancer.

[67]  N. DiBella,et al.  Reversible central nervous system dysfunction due to tamoxifen in a patient with breast cancer. , 1984, Annals of internal medicine.

[68]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[69]  J. Bancroft,et al.  The neuroendocrine response to d-fenfluramine in women with premenstrual depression. , 1995, Journal of affective disorders.

[70]  C. Shively.  BEHAVIORAL AND NEUROBIOLOGICAL EFFECTS OF ESTROGEN REPLACEMENT THERAPY AND A HISTORY OF TRIPHASIC ORAL CONTRACEPTIVE EXPOSURE , 1998, Psychoneuroendocrinology.

[71]  S. Inoue,et al.  Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. , 1997, Biochemical and biophysical research communications.

[72]  N. Rojansky,et al.  Estrogen augments serotonergic activity in postmenopausal women , 1995, Biological Psychiatry.

[73]  G. Fink,et al.  Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. , 1997, Brain research. Molecular brain research.

[74]  B. Lerer,et al.  Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. , 1998, The international journal of neuropsychopharmacology.

[75]  M. Linnoila,et al.  Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates. , 1995, The American journal of psychiatry.

[76]  S. Manuck,et al.  Neuroendocrine responses to fenfluramine challenge are influenced by exposure to chronic social stress in adult male cynomolgus macaques , 1994, Psychoneuroendocrinology.

[77]  D. Vaughn,et al.  A rostrocaudal gradient for neurotransmitter metabolites and a caudorostral gradient for protein in canine cerebrospinal fluid. , 1988, American journal of veterinary research.

[78]  L. Uphouse.  Female gonadal hormones, serotonin, and sexual receptivity , 2000, Brain Research Reviews.

[79]  Kristine Coleman,et al.  Anxious Behavior and Fenfluramine-Induced Prolactin Secretion in Young Rhesus Macaques with Different Alleles of the Serotonin Reuptake Transporter Polymorphism (5HTTLPR) , 2004, Behavior genetics.

[80]  S. Garattini,et al.  From Fenfluramine Racemate to d‐Fenfluramine , 1987 .

[81]  M. Wilson,et al.  Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary-adrenal axis in female monkeys , 2003, Endocrine.

[82]  T. Dinan,et al.  d‐Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen‐induced alteration , 1991, Clinical endocrinology.

[83]  S. Maier,et al.  8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. , 1995, Behavioral neuroscience.

[84]  Arpels Jc.  The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. , 1996 .

[85]  J. Costantino,et al.  Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study. , 2001, Journal of the National Cancer Institute.

[86]  J. Mann,et al.  Central Nervous System Monoamine Correlates of Social Dominance in Cynomolgus Monkeys (Macaca fascicularis) , 2002, Neuropsychopharmacology.

[87]  A. Guidotti,et al.  Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Herndon,et al.  Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys , 2002, Neurobiology of Aging.